Back to search
Breast Cancer-Related Lymphedema
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer-Related Lymphedema trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer-Related Lymphedema trials you may qualify forThis study aims to determine the combined effect of resisted deep breathing and Myofascial release on pain, respiratory efficiency, chest mobility and lymph ede…
This study is being done to find out how many women develop lymphedema after an axillary lymph node dissection. The investigators also want to look for reasons…
The goal of this clinical trial is to evaluate the effectiveness of Immediate Lymphatic Reconstruction (ILR) in preventing breast cancer-related lymphedema (BCR…
Breast cancer is the most common type of cancer among women globally and has the highest mortality rate. Surgical interventions are typically required in the tr…
Breast cancer is the most common cancer among women worldwide and lymphedema is one of its most significant complications. Breast cancer-related lymphedema (BCR…
Breast cancer is estimated to affect approximately 300,000 women in the US in 2023. Studies demonstrate that 1 in 5 will develop breast cancer related lymphedem…
This research study is a Pilot Study examining the use of a compression sleeve with embedded sensor to prevent lymphedema.
This randomized trial will test the effect of a prospective surveillance program for early detection and subclinical management of breast cancer-related lymphed…
In this study, researchers aimed to evaluate walking function, balance, and fall risk in patients with breast cancer-related lymphedema. The researchers' hypoth…